Faculty
-
August 30, 2016
Robert Klitzman on EpiPen's Price Hike
With EpiPen price-gouging in the news, Columbia's School of Professional Studies Bioethics Program Director, Dr. Robert Klitzman, has a new op-ed in CNN about the ethical questions raised by drug companies' overcharging patients. It's a tangled story of the principles of medicine, the profit priorities of private companies, and the taxpayers' money that creates these innovations.
Read the full article at CNN.
Faculty
Crashonda Andrew, senior vice president of global philanthropy at United Way, discussed fundraising strategy, donor engagement, and the evolving role of philanthropy during a Nonprofit Management Lunch and Learn session.
Faculty
Despite political hostility, the United States remains fundamentally shaped and strengthened by immigrants.
Faculty
An event hosted by the M.S. in Human Capital Management program demoed AI uses in learning management.
All News
